Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19-Reference-Cited by-同舟云学术

Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19

Published:2021 Issue: Volume:4 Page:100091
ISSN:2589-9090
Container-title:Journal of Translational Autoimmunity
language:en
Short-container-title:Journal of Translational Autoimmunity

Author:

Anaya Juan-Manuel,Monsalve Diana M.,Rojas Manuel,Rodríguez Yhojan,Montoya-García Norma,Mancera-Navarro Laura Milena,Villadiego-Santana Ana María,Rodríguez-Leguizamón Giovanni,Acosta-Ampudia Yeny,Ramírez-Santana Carolina

Funder

Universidad del Rosario

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference32 articles.

1. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19;Rodríguez;J. Autoimmun.,2020

2. Clinical and autoimmune characteristics of severe and critical cases of COVID-19;Zhou;Clin. Transl. Sci.,2020

3. Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity;Bertin;Arthritis Rheum.,2020

4. Immunoserologic detection and diagnostic relevance of cross-reactive autoantibodies in coronavirus disease 2019 patients;Schiaffino;J. Infect. Dis.,2020

5. Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome;Borghi;Front. Immunol.,2020

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of latent and overt polyautoimmunity in type 1 diabetes: A systematic review and meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-07

2. Prevalence and factors associated with thyroid autoimmunity among children newly diagnosed with type 1 diabetes before and during the COVID‐19 pandemic: Evidence from Kuwait;Diabetes/Metabolism Research and Reviews;2024-06-05

3. Autoimmunity in centenarians. A paradox;Journal of Translational Autoimmunity;2024-06

4. Post-COVID-19 syndrome: When an acute infection causes a chronic illness;Acta Colombiana de Cuidado Intensivo;2024-06

5. The development of anticyclic citrullinated peptide (anti‐CCP) antibody following severe COVID‐19;Immunity, Inflammation and Disease;2024-05